Jensen, C D <br/><br/>
Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study.  [electronic resource] 

 -  The Journal of bone and joint surgery. British volume  Jan 2011 
 - 91-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2044-5377 
<br/><br/><label>Standard No.: </label>10.1302/0301-620X.93B1.24987  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Arthroplasty, Replacement, Hip--adverse effects<br/>Arthroplasty, Replacement, Knee--adverse effects<br/>Female<br/>Fibrinolytic Agents--adverse effects<br/>Heparin, Low-Molecular-Weight--therapeutic use<br/>Hip Prosthesis--adverse effects<br/>Humans<br/>Knee Prosthesis--adverse effects<br/>Male<br/>Middle Aged<br/>Morpholines--adverse effects<br/>Postoperative Care--methods<br/>Postoperative Complications--prevention & control<br/>Prosthesis-Related Infections--etiology<br/>Reoperation<br/>Retrospective Studies<br/>Rivaroxaban<br/>Thiophenes--adverse effects<br/>Thromboembolism--prevention & control<br/>Tinzaparin